You are here

Resverlogix

Failed pivotal study? You can still have breakthrough therapy status — FDA signals to Resverlogix

Endpoints

Mon, 02/3/20 - 10:59 am

breakthrough therapy

clinical trials

Resverlogix gets FDA input, redesigns kidney trial

BioPharma Dive

Fri, 02/24/17 - 11:35 am

kidney dialysis

Resverlogix gets a $116M China drug development deal, stokes buyout buzz

Fierce Biotech

Wed, 04/29/15 - 08:16 am

Resverlogix Places A BET On RVX-208

Seeking Alpha

Thu, 06/5/14 - 11:54 am

BET-protein inhibitors

atherosclerosis

Resverlogix Plunges 93% After Drug Trial Fails

Bloomberg

Fri, 06/28/13 - 11:51 am

A Successful Phase 2b Study Isn't As Meaningful As It Used To Be

Forbes

Wed, 09/5/12 - 12:41 pm

clinical trials

Resverlogix Falls on Merck's `Huge Success' With Rival Cholesterol Drug

Bloomberg

Wed, 11/17/10 - 12:57 pm

Pfizer Cholesterol Failures Cleared Path for Canadian Upstart

Bloomberg

Fri, 03/5/10 - 09:50 am

Resverlogix: The Canadian Biotech Blockbuster

Minyanville

Mon, 10/5/09 - 10:38 am

Alzheimer's disease